The cause for the discordant (b)(6) results is unknown.The patient sample is not available for additional testing at the manufacturer's site.Siemens healthcare diagnostics is unable to determine root cause.The appears to be a sample specific issue.The interpretation of results section of the instructions for use (ifu) state: "results should always be interpreted in conjunction with the patient's medical history, clinical presentation, and other findings." the limitations section of the ifu states: "a nonreactive test result does not exclude the possibility of exposure to or infection with syphilis.T.Pallidum antibodies may be undetectable in some stages of the infection and in some clinical conditions.Assay performance characteristics have not been established when the advia centaur syph assay is used in conjunction with other manufacturers' assays for specific syphilis serological markers." the advia centaur syphilis (syph) ifu (10632392 rev.F, 2016-04 ous) states "the initial sensitivity of the advia centaur syph assay compared to reference assay 1 was 98.0% (700/714) with a 95% confidence interval of 96.7-98.9%.The advia centaur syphilis (syph) ifu (10632391 rev.F, 2016-04 us) states "the negative percent agreement of the advia centaur syph assay compared to the comparative assay was 98.4% (568/577) with a 95% confidence interval (ci) of 97.1 to 99.3%.".
|